-
FTC Keeps Pressure On Wall Street, Refiles Suit Against Allergan, Others
Monday, January 23, 2017 - 4:18pm | 271Read More...The Federal Trade Commission refiled complaints against multiple drug companies Monday for their efforts to block generic competitors of branded products. Endo Pharma And International In one case, the FTC filed an antitrust suit against Endo Pharmaceuticals Inc. and Endo International plc -...
-
Citigroup Releases Endo Pharmaceuticals Core Product Trends; Explains Price Target
Tuesday, October 26, 2010 - 8:15am | 104Read More...Citigroup has released its Endo Pharmaceuticals Holdings (NASDAQ: ENDP) core product trends for the week ending 10/15/2010. Lidoderm, Opana, and Frova are among the medications featured in the report. “We arrive at our $40 price target for Endo based on a relative 2011 P/E multiple compared to the...
